Detection of Invasive Colon Cancer Using a Novel, Targeted, Library-Derived Fluorescent Peptide

Sensitive methods to detect the earliest forms of colorectal cancers remain a challenge despite the development of serum and stool biomarkers. We reasoned that fluorescent affinity ligands derived from library screens can be developed to improve the detection and localization of early malignant lesions by endoscopy. We have developed an imaging agent for real-time endoscopic tumor detection in a murine model using a previously identified phage library-derived colon cancer-specific cyclic peptide and fluorescent moieties. The modified peptide had a 24 minute blood half life and tumoral accumulation was 6.9% of injected dose/g, ∼7-fold higher than a scrambled control peptide. Orthotopic colonic tumors (HT29) were readily detectable by fluorescence endoscopy even when tumors were submucosal. These results show proof-of-principle that disease-specific library-derived fluorescent probes can be rapidly developed for use in the early detection of cancers by optical means.

[1]  G. Lichtenstein,et al.  Colorectal cancer in inflammatory bowel disease , 2004, Current opinion in gastroenterology.

[2]  Ralph Weissleder,et al.  Miniaturized multichannel near infrared endoscope for mouse imaging. , 2003, Molecular imaging.

[3]  A. Kassner,et al.  Molecular Imaging of Angiogenesis in Nascent Vx-2 Rabbit Tumors Using a Novel ανβ3-targeted Nanoparticle and 1.5 Tesla Magnetic Resonance Imaging , 2003 .

[4]  David A Jones,et al.  Isolation of a colon tumor specific binding peptide using phage display selection. , 2003, Neoplasia.

[5]  R. Weissleder,et al.  Near-infrared fluorescent imaging of tumor apoptosis. , 2003, Cancer research.

[6]  Shelton D Caruthers,et al.  Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(nu)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging. , 2003, Cancer research.

[7]  R. Weissleder,et al.  Optical-based molecular imaging: contrast agents and potential medical applications , 2003, European Radiology.

[8]  D. Berger Plasmin/Plasminogen System in Colorectal Cancer , 2002, World Journal of Surgery.

[9]  Ralph Weissleder,et al.  Detection of dysplastic intestinal adenomas using enzyme-sensing molecular beacons in mice. , 2002, Gastroenterology.

[10]  Ahmedin Jemal,et al.  Cancer Statistics, 2002 , 2002, CA: a cancer journal for clinicians.

[11]  K. Arisawa,et al.  Biological Differences Between, Polypoid and Nonpolypoid Growth Types of Colorectal Cancer , 2000 .

[12]  T. Fujii,et al.  Flat and depressed colonic neoplasms: a prospective study of 1000 colonoscopies in the UK , 2000, The Lancet.

[13]  M. Albitar,et al.  Control of fibronectin receptor expression by fibronectin: Antisense fibronectin RNA downmodulates the induction of fibronectin receptor by transforming growth factor β1 , 1997, Journal of cellular physiology.

[14]  D. Rex,et al.  Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. , 1997, Gastroenterology.

[15]  T. Huang,et al.  Characterization of integrin expression and regulation on SW-480 human colon adenocarcinoma cells and the effect of rhodostomin on basal and upregulated tumor cell adhesion. , 1994, Biochimica et biophysica acta.

[16]  A. Zauber,et al.  Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. , 1993 .

[17]  E Farber,et al.  Cellular adaptation in the origin and development of cancer. , 1991, Cancer research.

[18]  Betty J. Flehinger,et al.  Colorectal cancer screening. , 1991, Journal of the National Cancer Institute.

[19]  E. E. Gresch Genetic Alterations During Colorectal-Tumor Development , 1989 .

[20]  N. Dubrawsky Cancer statistics , 1989, CA: a cancer journal for clinicians.

[21]  Y. Nakamura,et al.  Genetic alterations during colorectal-tumor development. , 1988, The New England journal of medicine.